Portal de Periódicos da CAPES

Development and validation of the International Hidradenitis Suppurativa Severity Score System ( IHS 4), a novel dynamic scoring system to assess HS severity

2017; Oxford University Press; Volume: 177; Issue: 5 Linguagem: Inglês

10.1111/bjd.15748

1365-2133

Christos C. Zouboulis, Thrasyvoulos Tzellos, Αthanassios Kyrgidis, Gregor B. E. Jemec, Falk G. Bechara, Evangelos J. Giamarellos‐Bourboulis, J.R. Ingram, Theodora Kanni, Ioannis Karagiannidis, A. Martorell, Łukasz Matusiak, Andreas Pinter, Errol P. Prens, Dagmar Presser, Sylke Schneider‐Burrus, Esther von Stebut, Jacek C. Szepietowski, Hessel H. van der Zee, Sophia Wilden, Robert Sabat, Rodney Sinclair, Dunja Ana Vekic, P. De Haes, V. del Mármol, Afsáneh Alavi, Wayne Gulliver, Aude Nassif, Georgios Nikolakis, Maurizio Podda, C. Antoniou, Florentina Delli, Clio Dessinioti, Aikaterini Patsatsi, Anastasia Trigoni, C. Zisimou, Vincenzo Bettoli, Simone Garcovich, Jurr Boer, Barbara Horváth, G. Ingvarsson, L. Puig, Robert E. Hunger, Lennart Emtestam, F. William Danby, Alexa B. Kimball,

Colorectal and Anal Carcinomas

A validated tool for the dynamic severity assessment of hidradenitis suppurativa/acne inversa (HS) is lacking. To develop and validate a novel dynamic scoring system to assess the severity of HS. A Delphi voting procedure was conducted among the members of the European Hidradenitis Suppurativa Foundation (EHSF) to achieve consensus towards an initial HS Severity Score System (HS4). Strengths and weaknesses of HS4 were examined by a multicentre prospective study. Multivariate logistic regression, discriminant analysis and receiver operating characteristic curves, as well as examination for correlation (Spearman's rho) and agreement (Cohen's kappa) with existing scores, were engaged to recognize the variables for a new International HS4 (IHS4) that was established by a second Delphi round. Consensus HS4 was based on number of skin lesions, number of skin areas involved and Dermatology Life Quality Index (DLQI), and was evaluated by a sample of 236 patients from 11 centres. Subsequently, a multivariate regression model calculated adjusted odds ratios for several clinical signs. Nodules, abscesses and draining tunnels resulted as the scoring variables. Three candidate scores were presented to the second Delphi round. The resulting IHS4 score is arrived at by the number of nodules (multiplied by 1) plus the number of abscesses (multiplied by 2) plus the number of draining tunnels (multiplied by 4). A total score of 3 or less signifies mild, 4–10 signifies moderate and 11 or higher signifies severe disease. Cohen's kappa was fair (κ = 0·32) compared with Hurley classification, and moderate (κ = 0·49) compared with Expert Opinion. Correlation was good (ρ > 0·6) with Hurley classification, Expert Opinion, Physician's Global Assessment and Modified Sartorius score, and moderate for DLQI (ρ = 0·36). The novel IHS4 is a validated tool to dynamically assess HS severity and can be used both in real‐life and the clinical trials setting.